MediciNova, Inc. Announces 2024 Annual Meeting of Stockholders on June 11, 2024

TL;DR

<b>MediciNova, Inc. invites stockholders to its 2024 Annual Meeting on June 11, 2024, with proxy materials available online.</b>

AI Summary

MEDICINOVA INC (MNOV) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. MediciNova, Inc. will hold its 2024 Annual Meeting of Stockholders on June 11, 2024, at 1:00 p.m. Pacific Daylight Time. The meeting will take place at 4275 Executive Square, Suite 300, La Jolla, California 92037. Proxy materials will be furnished to stockholders via the Internet, with a Notice of Internet Availability expected to be mailed around April 26, 2024. Stockholders can vote online, by telephone, or by mail if paper copies are received. The company encourages prompt voting, whether or not stockholders plan to attend the meeting.

Why It Matters

For investors and stakeholders tracking MEDICINOVA INC, this filing contains several important signals. The meeting date and location are critical for stockholders to exercise their voting rights and participate in corporate governance decisions. The shift to internet-based proxy materials reflects a trend towards digital communication and cost-efficiency in corporate disclosures.

Risk Assessment

Risk Level: low — MEDICINOVA INC shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, containing standard procedural information and no significant new financial or strategic disclosures that would indicate immediate high risk.

Analyst Insight

Stockholders should review the proxy materials carefully to understand the proposals being voted on and ensure their vote is cast by the deadline.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Key Numbers

• June 11, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
• 1:00 p.m. Pacific Daylight Time — Annual Meeting Time (2024 Annual Meeting of Stockholders)
• 4275 Executive Square, Suite 300, La Jolla, California 92037 — Meeting Location (Physical address for the 2024 Annual Meeting)
• April 26, 2024 — Notice Mailing Date (Expected date for mailing Notice of Internet Availability)

Key Players & Entities

• MediciNova, Inc. (company) — Registrant and filer of the proxy statement
• June 11, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders
• April 26, 2024 (date) — Expected mailing date of the Notice of Internet Availability of Proxy Materials
• Yuichi Iwaki, M.D., Ph.D. (person) — President, Chief Executive Officer and Director of MediciNova, Inc.
• ADVANTAGE PROXY (company) — Proxy solicitor for MediciNova, Inc.

FAQ

Industry Context

MediciNova, Inc. operates in the pharmaceutical preparations industry, focusing on the development and commercialization of drugs.

Regulatory Implications

This filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

What Investors Should Do

1. Review the proxy statement for details on proposals and director nominations.
2. Vote your shares by the deadline using the provided internet, telephone, or mail options.
3. Attend the annual meeting on June 11, 2024, if possible, to vote in person.

Key Dates

• 2024-06-11: 2024 Annual Meeting of Stockholders — Key date for stockholders to vote and participate in company decisions.
• 2024-04-26: Mailing of Notice of Internet Availability of Proxy Materials — Indicates when stockholders can access proxy materials online.

Year-Over-Year Comparison

This filing is a Definitive Proxy Statement (DEF 14A) for the 2024 Annual Meeting, indicating it's the final version for distribution to shareholders, following the typical annual filing cycle.

Key Financial Figures

• $0.001 — r shares of our common stock, par value $0.001 per share (the Common Stock). The docum
• $4,800 — Proxy will be paid its customary fee of $4,800 plus reimbursement of up to $1,200 in o
• $1,200 — e of $4,800 plus reimbursement of up to $1,200 in out-of-pocket expenses to solicit pr

Filing Documents

• mnov_proxy_2024.htm (DEF 14A) — 670KB
• img138344840_0.jpg (GRAPHIC) — 4KB
• img138344840_1.jpg (GRAPHIC) — 1KB
• img138344840_2.jpg (GRAPHIC) — 4KB
• img138344840_3.jpg (GRAPHIC) — 1KB
• img138344840_4.jpg (GRAPHIC) — 268KB
• img138344840_5.jpg (GRAPHIC) — 271KB
• img138344840_6.jpg (GRAPHIC) — 1KB
• 0000950170-24-049146.txt (&nbsp;) — 1429KB

From the Filing

DEF 14A 1 mnov_proxy_2024.htm DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 MEDICINOVA, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. April 26, 2024 Dear Stockholders of MediciNova, Inc.: You are cordially invited to attend the 2024 Annual Meeting of Stockholders of MediciNova, Inc. The meeting will be held on Tuesday, June 11, 2024 at 1:00 p.m. Pacific Daylight Time at 4275 Executive Square, Suite 300, La Jolla, California 92037. We are pleased to take advantage of the Securities and Exchange Commission rules that allow companies to furnish proxy materials to their stockholders on the Internet. On or around April 26, 2024, we expect to mail to our stockholders a Notice of Internet Availability of Proxy Materials (the Notice) containing instructions on how to access our Proxy Statement for our 2024 Annual Meeting of Stockholders and Annual Report for the year ended December 31, 2023 (the 2023 Annual Report). The Notice also provides instructions on how to vote online and how to receive a paper copy of the proxy materials by mail. Whether or not you plan to attend the meeting, your vote is very important and we encourage you to vote promptly . You may vote by proxy over the internet or by telephone, or, if you received paper copies of the proxy materials by mail, you can also vote by mail by following the instructions on your proxy card. If you attend the meeting you will have the right to revoke your proxy and vote your shares in person. If you hold your shares through an account with a brokerage firm, bank or other nominee, please follow the instructions you receive from your brokerage firm, bank or other nominee to vote your shares. The Board of Directors and management of MediciNova, Inc. look forward to seeing you at the meeting. Sincerely yours, Yuichi Iwaki, M.D., Ph.D. President, Chief Executive Officer and Director If you have questions about the proposals or how to vote your shares, you may contact our proxy solicitor: ADVANTAGE PROXY (877) 870-8565 (toll free) NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 11, 2024 To the Stockholders of MediciNova, Inc.: NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d; or &#x201c;2024 Annual Meeting&#x201d;) of MediciNova, Inc., a Delaware corporation (we, us, our, MediciNova or the Company), will be held on Tuesday, June 11, 2024 at 1:00 p.m. Pacific Daylight Time at 4275 Executive Square, Suite 300, La Jolla, California 92037 for the following purposes: 1. To elect each of Yuichi Iwaki and Kazuko Matsuda as a Class II director of the Company, as recommended for nomination by our Nominating and Corporate Governance Committee and approved by our Board of Directors, to hold office until the 2027 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or, if sooner, until his earlier death, resignation or removal; 2. To ratify the Audit Committee&#x2019;s selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and 3. To conduct any other business properly brought before the Annual Meeting. Stockholders of record as of the close of business on April 17, 2024 are entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. A complete list of stockholders entitled to vote at the Annual Meeting will be available for inspection at MediciNova&#x2019;s offices, located at 4275 Executive Square, Suite 300, La Jolla, California 92037, for ten days prior to the Annual Meeting. It is important that your shares are represented at the Annual Meeting. Even if you plan to attend the 2024 Annual Meeting in person, we encourage you to read the proxy statement and vote or submit your proxy as soon as possible so that your shares can be voted at the 2024 Annual Meeting in accordance with your instructions. Telephone and internet voting are available. For specific instructions on voting, please refer to the instructions in the Notice of Internet Availability of Proxy Materials (the Notice) you received, or your proxy card, if you have requested one. If you d

View Full Filing

View this DEF 14A filing on SEC EDGAR